Show results for
Refine by
Drug Platform Equipment & Supplies In Iran
24 equipment items found
Manufactured by:Rebiotix Inc., a Ferring Company based inRoseville, MINNESOTA (USA)
Rebiotix Inc., a Ferring Company, has leveraged its clinical, manufacturing and regulatory experience with RBX2660 to develop the first of its kind non-frozen, room temperature stable oral microbiota-based formulation under the MRT™ drug platform, known as RBX7455. While it is currently used to reduce the incidence of recurrent Clostridioides difficile ...
Manufactured by:Rebiotix Inc., a Ferring Company based inRoseville, MINNESOTA (USA)
Rebiotix Inc., a Ferring Company, has conducted several trials of the lead microbiota-based product in the MRT drug platform, RBX2660, for reducing the rate of recurrence of Clostridioides difficile infection. RBX2660 is currently under study in a Phase 3 clinical trial in conjunction with the US Food and Drug Administration’s ...
Manufactured by:Destiny Pharma plc based inBrighton, UNITED KINGDOM
The XF drug platform has a novel, ultra-rapid mechanism that reduces the chance of bacteria becoming resistant to its action. Destiny Pharma’s XF platform has advantages over traditional antibiotics. ...
Manufactured by:Gesynta Pharma AB based inStockholm, SWEDEN
The drug candidate GS-659, which is sprung from Gesynta Pharma’s drug development platform, is currently in preclinical development phase. Project updates will be announced in due ...
Manufactured by:Confo Therapeutics based inGhent/Zwijnaarde, BELGIUM
Confo Therapeutics is building a pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying ...
by:Theramx Inc. based inSeongnam-si, SOUTH KOREA
Drug delivery platform technology designed to maximize efficacy while simultaneously minimizing side effects of existing drugs by delivery to desired ...
Manufactured by:Skyepharma Production SAS based inSaint-Quentin-Fallavier, FRANCE
Geomatrix® (multi-layer tablet technology) is a well-established, validated and customizable oral drug delivery platform technology that is currently used in 8 products that are commercialized in over 80 countries. Geomatrix® is highly versatile and can be applied to a wide range of different drugs to achieve a variety of different ...
Manufactured by:InSphero AG based inSchlieren, SWITZERLAND
When you’re ready, we deliver. InSphero assay-ready spheroid microtissues are engineered and certified for use in critical drug development applications, and validated to ensure uniform size, robust functionality, and reproducible results. We develop 3D InSight™ Microtissues using the most advanced 3D cell culture technologies available to produce highly predictive, ...
by:Zymeworks Inc based inVancouver, BRITISH COLUMBIA (CANADA)
Deliver potent cell-killing compounds specifically to diseased target cells with optimal safety and efficacy. ZymeLink™, a next-generation antibody drug conjugate (ADC) platform, is a suite of proprietary cytotoxins (cell-killing compounds), stable linkers, and conjugation technologies. ZymeLink™ is compatible with traditional antibodies, proteins, ...
Manufactured by:Bexson Biomedical based inSanta Barbara, CALIFORNIA (USA)
Partnering with the Stevanato Group, we are creating the first modular, pre-filled, and pre-sterilized subcutaneous pump that can be utilized to deliver hundreds of ...
by:Orion Biotechnology Canada, Ltd. based inOttawa, SWITZERLAND
G Protein-Coupled Receptors (GPCRs) are involved in a wide range of physiological and pathological processes and represent a large class of drug targets accounting for >30% of all drugs on the market. These drugs, however, only cover 15% of the entire GPCR family, and many valuable receptors remain undrugged. In particular, GPCRs whose natural ligands are large peptides or small proteins are ...
Manufactured by:Galapagos NV based inMechelen, BELGIUM
Filgotinib, a preferential JAK1 inhibitor, is marketed as Jyseleca in the European Union (incl. Norway), Great Britain, and Japan for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have responded inadequately or are intolerant to one or more disease modifying anti-rheumatic drugs ...
Manufactured by:Benevolent based inLondon, UNITED KINGDOM
The Benevolent Platform™ is our powerful computational R&D platform. At its core sits our Knowledge Graph, which captures the interconnectivity of all relevant available data and scientific literature. Our suite of exploratory and predictive AI tools allow scientists to interrogate the data and disease networks within the graph, ask biological questions, surface novel ...
Manufactured by:SCHOTT Pharma based inMainz, GERMANY
SCHOTT Pharma's syriQ prefillable glass syringes are designed to streamline vaccine administration by eliminating most drug preparation steps. These syringes, made from FIOLAX® Borosilicate Glass, offer exceptional safety and usability. They are particularly well-suited for a variety of vaccines, including inactivated, live-attenuated, subunit, recombinant, polysaccharide, conjugate, and mRNA ...
Manufactured by:Intrommune Therapeutics based inNew York, NEW YORK (USA)
Intrommune has developed a novel drug delivery platform—oral mucosal immunotherapy (OMIT)—for the treatment of food allergies. Therapeutic agents are embedding in fully functioning toothpaste so that treatment can be conveniently administered during a patient’s daily toothbrushing ...
Manufactured by:Benevolent based inLondon, UNITED KINGDOM
The emerging global threat from COVID-19 demanded immediate action. With cases rising rapidly, we set up a specialist team to use our AI-drug discovery platform to search for existing drugs — already proven safe — that could be repurposed to treat the virus. We are the only AI company to successfully identify a drug ...
Manufactured by:Sonceboz SA based inSonceboz-Sombeval, SWITZERLAND
Device with two cartridge containers of selectable volume (2x3mL, 1x3mL and 1x5mL etc.). Shared injection system/fluid path Sequential or simulataneous injection of 2 APIs. Solution for Combination Therapies or Lifecycle-Management in cases where the API is already filled in a smaller volume cartridge container -> Time to ...
by:Microba Life Sciences based inBrisbane City, AUSTRALIA
Developing novel therapeutics from the human microbiome; The uncultured portion of the human gut microbiome, which is the majority of microbial species, represents untapped therapeutic opportunity. Microba has established a platform for drug discovery and development that leverages a growing, proprietary Databank of human microbiome samples and associated ...
Manufactured by:Sonceboz SA based inSonceboz-Sombeval, SWITZERLAND
Acoustic and optical feedback. Prefilled and Loaded or User-Loaded. WhisperDrive™ 35dBA. 27G Soft-cannula needle insertion system. Optional connectivity via Bluetooth Low Energy. Glass cartridge based 3mL, 5mL, 10mL, 15mL, 20mL (larger volumes on request). Dosing rate programmable 0 - 1,5mL/min @ viscosity 50cPs. 50nL minimal dose increment. Dead-Volume ...
Manufactured by:Sonceboz SA based inSonceboz-Sombeval, SWITZERLAND
Manual Reconstitution of lyophilized drug formulations is a complex procedure and challenging for patients and caregivers alike. The ARI automatically facilitates the mixing of diluent and lyophilized drug in a easy-to-use fashion without the need of external mixing stations. Furthermore a built-in sensor suite monitors the proper agitation and mixing of the reconstituted formulation prior to ...